In chronic hepatitis B, the liver contains immune cells that could destroy hepatitis B virus infected cells but are inactive. A team from the Technical University of Munich (TUM) has discovered that cells blood vessels in the liver start a “sleep timer” that switches off immune cells. Targeting this mechanism could be a starting point for immunotherapies.
NIDA should beware of funding companies that violate people’s privacy
In a ground-breaking settlement with the Federal Trade Commission, two online addiction and mental health treatment companies, Monument and Cerebral, admitted to deceptively and widely